ArticleOncotarget2016

Combination therapy of RY10-4 with the γ-secretase inhibitor DAPT shows promise in treating HER2-amplified breast cancer.

Feng Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.